Rachel Flehinger
Articles by Rachel Flehinger
| 3 min read
MANF Therapeutics restarts IND-enabling work in light of new results
| 3 min read
Melinta Therapeutics seeks to move investigational pyrrolocytosine compounds into clinical stage
| 3 min read
A pair of new deals with Daiichi and Takeda help move Thermo’s technology forward
| 3 min read
Sutro Biopharma advances STRO-001 and STRO-002 into the clinic against multiple cancer types
| 3 min read
Scripps scientists use 3D spheroids to better test cancer drugs’ efficacy
| 3 min read
Combination of immune agonists may fight one of the fastest-moving and deadliest of cancers
| 3 min read
QIAGEN acquires molecular diagnostics company STAT-Dx and its multiplex technologies
| 2 min read
With half of CAR-T studies in China, Cesca looks to capitalize on market potential with CDMO expansion
| 3 min read
CD133 revealed as a potential target for encouraging kidney repair
